Medicinal Plant

2020, v.11(03) 87-89

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

Clinical Observation of Huatanjieyu Granule in the Treatment of Post-stroke Depression
Clinical Observation of Huatanjieyu Granule in the Treatment of Post-stroke Depression

Xi WANG;Chunqi AI;Lizhu LIU;Dongyu XIA;Qin GONG;

摘要(Abstract):

[Objectives] To observe the clinical effect of Huatanjieyu granule on patients with post-stroke depression. [Methods] Total 76 patients with confirmed post-stroke depression were randomly divided into two groups(treatment group and control group) according to the double-blind principle. The treatment group(38 cases) was treated with Huatanjieyu granule combined with escitalopram, and the control group(38 cases) was treated with escitalopram alone. The course of treatment was 6 weeks. Through clinical efficacy, Hamilton Depression Scale(HAMD) and Treatment Emergent Symptom Scale(TESS) scores were compared, and blood, liver function, renal function and electrocardiogram were examined. [Results] The scores of HAMD and TESS in patients with post-stroke depression were significantly decreased by Huatanjieyu granule, and there were no obvious side effects. The total effective rate was 92.1% in the treatment group and 76.3% in the control group. There was significant difference between the two groups(P<0.01). [Conclusions] Huatanjieyu granule was effective in the treatment of post-stroke depression with little side effects and was easy to be accepted by patients.

关键词(KeyWords):

Abstract:

Keywords:

基金项目(Foundation): Supported by the Hospital-level Project of Shiyan Taihe Hospital in 2018(2018JJXM092);; Shiyan Science and Technology Research and Development Project in 2018(18Y17)

作者(Author): Xi WANG;Chunqi AI;Lizhu LIU;Dongyu XIA;Qin GONG;

Email:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享